Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Metsera
Developing next-gen obesity therapies
Biotech
Pfizer beats out Novo with $10B agreement to buy Metsera
After a chaotic bidding clash that only burst out into public view nine days ago, Pfizer has prevailed in its pursuit of obesity biotech Metsera.
Eric Sagonowsky
Nov 8, 2025 8:11am
Novo CEO tells Pfizer to 'bid higher' if it wants to win Metsera
Nov 7, 2025 10:00am
Judge denies Pfizer’s bid to block Novo’s offer for Metsera
Nov 5, 2025 5:23pm
FTC tells Novo that Metsera offer may violate US merger law
Nov 5, 2025 4:26pm
Novo Nordisk CEO 'feels' Danish pharma will bag Metsera
Nov 5, 2025 4:20am
Pfizer pulls the plug on 11 programs
Nov 4, 2025 2:40pm
